Showing results (121-130 of 209) with videos related to
Sort By:
Pageof 21
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|May 9, 2024
Validation of the Onset of Effect Questionnaire in Participants With Chronic Obstructive Pulmonary DiseaseCharlie Strange, Barry J Make, Frank J Trudo, et al.International Journal of Chronic Obstructive Pulmonary Disease|October 10, 2015
Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatmentsFrank Trudo, David M Kern, Jill R Davis, et al.COPD|July 19, 2013
Safety and pharmacokinetics of 120 mg/kg versus 60 mg/kg weekly intravenous infusions of alpha-1 proteinase inhibitor in alpha-1 antitrypsin deficiency: a multicenter, randomized, double-blind, crossover study (SPARK)Michael A Campos, Friedrich Kueppers, James M Stocks, et al.Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|December 5, 2024
Improving the Likelihood of Identifying Alpha-1 Antitrypsin Deficiency Among Patients With COPD: A Novel Predictive Model Using Real-World DataDaniel N Pfeffer, Rahul Dhakne, Omnya El Massad, et al.International Journal of Chronic Obstructive Pulmonary Disease|December 10, 2021
Feasibility of RESP-FIT: Technology-Enhanced Self-Management Intervention for Adults with COPDSarah Miller, Ronald Teufel, Michelle Nichols, et al.International Journal of Behavioral Medicine|July 11, 2014
The social environment and illness uncertainty in chronic obstructive pulmonary diseaseKarin F Hoth, Frederick S Wamboldt, Dee W Ford, et al.Journal of Managed Care & Specialty Pharmacy|November 25, 2022
Prompt initiation of triple therapy following hospitalization for a chronic obstructive pulmonary disease exacerbation in the United States: An analysis of the PRIMUS studyKristin A Evans, Michael Pollack, Edward Portillo, et al.Genetic Testing|December 17, 2008
Barriers to genetic testing among persons at risk for alpha-1 antitrypsin deficiencyMarguerite R Dickson, Cindy L Carter, Matthew J Carpenter, et al.International Journal of Chronic Obstructive Pulmonary Disease|February 18, 2022
PRIMUS - Prompt Initiation of Maintenance Therapy in the US: A Real-World Analysis of Clinical and Economic Outcomes Among Patients Initiating Triple Therapy Following a COPD ExacerbationJoseph Tkacz, Kristin A Evans, Daniel R Touchette, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 12, 2005
Factors associated with advanced liver disease in adults with alpha1-antitrypsin deficiencyChristopher L Bowlus, Ira Willner, Mark A Zern, et al.Pageof 21